1. Minimally Invasive Pancreatoduodenectomy: Contemporary Practice, Evidence, and Knowledge Gaps

   • Jacob Ghotbi
   • Mushegh Sahakyan
   • Dyre Kleive

   Commentary Open access 12 July 2022 Pages: 301 - 315

2. Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management

   • Piyu Parth Naik
   • Munaf B. Desai

   Review Open access 21 June 2022 Pages: 317 - 335

   

3. The Implementation of Minimally Invasive Surgery in the Treatment of Esophageal Cancer: A Step Toward Better Outcomes?

   • Tania Triantafyllou
   • Pieter van der Sluis
   • Bas P. L. Wijnhoven

   Review Open access 10 August 2022 Pages: 337 - 349

4. Pegfilgrastim Biosimilars in US Supportive Oncology: A Narrative Review of Administration Options and Economic Considerations to Maximize Patient Benefit

   • Sophia Z. Humphreys
   • Robert B. Geller
   • Paul Walden

   Review Open access 16 September 2022 Pages: 351 - 361

   

5. The Anticancer Effect of Metformin Combined with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients with or Without Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

   • Qiman Zhang
   • Jin Zheng
   • Fei-Long Wei

   Review Open access 25 October 2022 Pages: 363 - 375

   

6. The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines

   • Atiye Saeedi Sadr
   • Hassan Ehteram
   • Hamed Haddad Kashani

   Original Research Open access 25 April 2022 Pages: 377 - 388

   

7. Correction to: The Effect of Irisin on Proliferation, Apoptosis, and Expression of Metastasis Markers in Prostate Cancer Cell Lines

   • Atiye Saeedi Sadr
   • Hassan Ehteram
   • Hamed Haddad Kashani

   Correction Open access 12 May 2022 Pages: 389 - 389

8. Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT)

   • Jason T. Hurwitz
   • Shannon Vaffis
   • Suzanne Parry

   Original Research Open access 13 May 2022 Pages: 391 - 409

   

9. Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States

   • Sundar Jagannath
   • Nedra Joseph
   • Nina Shah

   Original Research Open access 17 May 2022 Pages: 411 - 420

10. Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making

    • Thomas W. LeBlanc
    • Nigel H. Russell
    • Roland B. Walter

    Original Research Open access 13 June 2022 Pages: 421 - 440

    

11. Breast Cancer with Low Recurrence Score on Oncotype DX^©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation

    • Yonaton Zarbiv
    • Yael Berner Wygoda
    • Luna Kadouri

    Original Research Open access 25 June 2022 Pages: 441 - 450

    

12. Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer

    • Hassan Ehteram
    • Fatemeh Aslanbeigi
    • Hamed Haddad Kashani

    Original Research Open access 18 August 2022 Pages: 451 - 461

    

13. Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study

    • Scott Paulson
    • David Ray
    • Eric Liu

    Original Research Open access 22 September 2022 Pages: 463 - 479

    

14. The Role of Electronic Patient-Reported Outcome Measures in Assessing Smoking Status and Cessation for Patients with Lung Cancer

    • James Convill
    • Fiona Blackhall
    • Fabio Gomes

    Original Research Open access 12 October 2022 Pages: 481 - 491

    

15. MRI Grading Scale Predicts Ambulatory Function After Radiotherapy for Metastatic Spinal Cord Compression: A Prospective Single-Institution Observational Study

    • Natsuko Yano
    • Takashi Ono
    • Kenji Nemoto

    Brief Report Open access 19 July 2022 Pages: 493 - 501